Copyright 2008 Medical News Today Latest Parkinson's Disease News From Medical News Today. http://www.medicalnewstoday.com/sections/parkinsons_disease/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Fri, 29 Aug 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/119636.php Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announces that results of the phase III ADAGIO trial were presented today during the 12th Congress of European Federation of Neurological Societies (EFNS) in Madrid, Spain as part of a "Late Breaking News" session. Parkinson's Disease Fri, 29 Aug 2008 03:00:00 PDT http://www.medicalnewstoday.com/articles/119612.php The British Midlands Development Corporation today announced that scientists at The University of Nottingham have made a crucial breakthrough in the battle to slow or prevent the onset of a very common type of dementia and Parkinson's disease. Parkinson's Disease Fri, 29 Aug 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/119594.php The 3rd Annual Southeastern Parkinson Disease Conference will be held at Berry College in Rome, Georgia on November 6 - 8, 2008. Nationally and Internationally recognized experts in their fields will present programs on various aspects of living with Parkinson Disease. Early Registration is $75. Parkinson's Disease Wed, 27 Aug 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/119308.php Data presented during the 12th Congress of the European Federation of Neurological Sciences (EFNS), held in Madrid, Spain, from 23 to 26 August, highlight important new ongoing studies with pramipexole in a number of key research areas in Parkinson's disease (PD): clinical benefits of early treatment initiation, management of PD-related depressive symptoms and a new formulation currently under investigation. Parkinson's Disease Wed, 27 Aug 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/119310.php The European Parkinson's Disease Association (EPDA) urged European decision makers and politicians to end inequalities in care and treatment access for people with Parkinson's disease. The plea was made during the launch of EPDA's latest campaign, 'Parkinson's is visible, make it livable', intended to visualise the daily challenges faced by those with Parkinson's, increase people's knowledge and understanding of the disease and influence decision makers. Parkinson's Disease Sun, 24 Aug 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/118912.php Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced that it has received Institutional Review Board approvals to begin recruiting and enrolling participants for its Phase 2 clinical trial of the company's gene transfer approach to the treatment of advanced Parkinson's disease. Parkinson's Disease Sat, 23 Aug 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/118944.php New research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, provides evidence that one of the only naturally occurring fatty acids in the brain that has the ability to interact with the receptors originally identified as the targets of THC (the psychoactive component of marijuana) can help to protect brain cells from neurodegenerative diseases like Alzheimer's and Parkinson's. Alzheimer's / Dementia Fri, 22 Aug 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/118968.php Plastic coatings could someday help neural implants treat conditions as diverse as Parkinson's disease and macular degeneration. The coatings encourage neurons in the body to grow and connect with the electrodes that provide treatment. Jessica O. Winter, assistant professor of chemical and biomolecular engineering at Ohio State University described the research at the American Chemical Society meeting in Philadelphia. Neurology / Neuroscience Sun, 17 Aug 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/118436.php In a first-time collaboration, Hubbard Street Dance Chicago (HSDC) is working with Rush University Medical Center to launch a pilot program in contemporary dance specifically designed for people with Parkinson's disease and related movement disorders. The class, which features live piano accompaniment, takes place Saturdays from 1 p.m. to 2:15 p.m. at the Hubbard Street Dance Center, 1147 W. Jackson Blvd., in Chicago. The next 12-week fall session begins Saturday, September 6. Parkinson's Disease Sat, 16 Aug 2008 03:00:00 PDT http://www.medicalnewstoday.com/articles/118382.php Parkinson disease (PD) is a debilitating and lethal neurodegenerative disease, for which there is currently no cure. It is caused by the progressive loss of nerve cells that produce the chemical dopamine and is characterized by the accumulation of abnormal aggregates of a protein called alpha-syn in these dopaminergic nerve cells. Parkinson's Disease Sat, 16 Aug 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/118424.php Researchers at the University of Pennsylvania School of Medicine have identified a protein from a most unlikely source -- baker's yeast -- that might protect against Parkinson's disease. More than a million Americans suffer from Parkinson's disease, and no treatments are available that fundamentally alter the course of the condition. Parkinson's Disease Thu, 14 Aug 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/118210.php Results from a recent survey conducted by the Parkinson's Disease Society (PDS) reveal a lack of knowledge on the mental health issues associated with Parkinson's amongst health and social professionals in England. Over 470 professionals, including GPs, social workers, and nurses* responded to an online questionnaire designed to identify current levels of knowledge and to assess future training needs. Parkinson's Disease Mon, 11 Aug 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/117818.php As people age, their cells become less efficient at getting rid of damaged protein - resulting in a buildup of toxic material that is especially pronounced in Alzheimer's, Parkinson's disease, and other neurodegenerative disorders. Seniors / Aging Mon, 11 Aug 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/117797.php Parkinson's disease and drug addiction are polar opposite diseases, but both depend upon dopamine in the brain. Parkinson's patients don't have enough of it; drug addicts get too much of it. Although the importance of dopamine in these disorders has been well known, the way it works has been a mystery. Parkinson's Disease Sun, 10 Aug 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/117444.php As people age, their cells become less efficient at getting rid of damaged protein - resulting in a buildup of toxic material that is especially pronounced in Alzheimer's, Parkinson's disease, and other neurodegenerative disorders. Seniors / Aging Fri, 08 Aug 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/117648.php A set of new stem cell lines will make it possible for researchers to explore ten different genetic disorders-including muscular dystrophy, juvenile diabetes, and Parkinson's disease-in a variety of cell and tissue types as they develop in laboratory cultures. Researchers led by Howard Hughes Medical Institute investigator George Q. Daley have converted cells from individuals with the diseases into stem cells with the same genetic errors. Stem Cell Research Thu, 31 Jul 2008 03:00:00 PDT http://www.medicalnewstoday.com/articles/116650.php A cross-national project on Parkinson disease assessment calls the attention for the role of behavioral factors in Parkinson disease. The study points to new trends in Parkinson's disease assessment, which eventually would expand to social functioning ascertainment. Parkinson's Disease Wed, 30 Jul 2008 03:00:00 PDT http://www.medicalnewstoday.com/articles/116565.php Gene silencing techniques and induced pluripotent stem cell technology are among the cutting-edge approaches to Parkinson's drug development funded through The Michael J. Fox Foundation's Rapid Response Innovation Awards 2008. As part of its mission to drive transformative treatments and a cure for PD, the Foundation has awarded $1.1 million for 15 high-risk, high-reward Parkinson's disease research projects under the initiative in the first half of the year. Parkinson's Disease Wed, 30 Jul 2008 03:00:00 PDT http://www.medicalnewstoday.com/articles/116566.php A new drug that has completed phase 2 trials in the UK and Singapore is being hailed as a major breakthrough in the treatment of Alzheimer's, as it appeared to slow the progress of the disease by as much as 81 per cent over a year, compared to placebo. Methylthioninium chloride (MTC) blocks the accumulation of tau protein tangles inside brain cells, one of the principal characteristics of the disease that was originally discovered by Alois Alzheimer 100 years ago. Alzheimer's / Dementia Fri, 25 Jul 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/116174.php Adult stem cells originate in a different part of the brain than is commonly believed, and with proper stimulation they can produce new brain cells to replace those lost to disease or injury, a study by UC Irvine scientists has shown. Evidence strongly shows that the true stem cells in the mammalian brain are the ependymal cells that line the ventricles in the brain and spinal cord, rather than cells in the subventricular zone as biologists previously believed. Stem Cell Research Wed, 23 Jul 2008 05:00:00 PDT http://www.medicalnewstoday.com/articles/115878.php 1. Modeling Electrophysiological Diversity Variations in morphology and ion-channel expression largely determine the electrophysiological properties of neurons. To investigate whether such variations are sufficient to explain the electrophysiological variability of globus pallidus neurons recorded in brain slices, Gunay et al. created more than 100,000 computer models using three realistic morphologies and variable levels of nine ionic conductances. Neurology / Neuroscience Tue, 22 Jul 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/115756.php What does the genetics of blood cells have to do with brain cells related to Parkinson's disease? From an unusual collaboration of neurologists and a pharmacologist comes the surprising answer: Genetic mechanisms at play in blood cells also control a gene and protein that cause Parkinson's disease. Parkinson's Disease Sat, 19 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/115383.php The Michael J. Fox Foundation for Parkinson's Research has announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative. This annual MJFF program provides intellectual and financial resources to help push potential PD drug targets forward toward clinical trials and ultimately the nearly five million Parkinson's patients worldwide. Parkinson's Disease Mon, 14 Jul 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/114840.php A typical symptom of Parkinson's disease is tremor in patients. A group of scientists, including Professor Peter Tass from Forschungszentrum Julich have succeeded in demonstrating the mechanisms which cause the so-called tremor: neuron clusters in the depths of the brain drive the tremor. This discovery supports Tass' research activities aiming at developing a therapy for Parkinson's disease. A new deep brain pacemaker is to bring cells out of the diseased mode for good. Parkinson's Disease Fri, 04 Jul 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/113908.php Titan Pharmaceuticals, Inc. (AMEX:TTP) announced initial analyses show that Spheramine® did not meet the Phase IIb clinical study's primary or key secondary endpoints, with no significant differences detected between the Spheramine and sham surgery arms of the study after 12 months of follow-up. Parkinson's Disease